Ustekinumab and Omalizumab
Supply of Ustekinumab and Omalizumab to NHS Scotland
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£70,000,000
Published
28 Jun 2024
Closes
29 Jul 2024
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Ustekinumab
Value not provided
Supply of Ustekinumab presentations to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of six (6) Framework Participants. This Lot will be awarded from 1 October 2024, for 24 months, with an expiry date of 30 September 2026. This Lot has the option to extend by any number of periods,...
Delivery: Scotland
Lot 2 Omalizumab
Value not provided
Supply of Omalizumab presentations to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 October 2024, for 24 months, with an expiry date of 30 September 2026. This Lot has the option to extend by any number of periods...
Delivery: Scotland
Documents
Unlock document linkUstekinumab and Omalizumab
Not provided
Supply of Ustekinumab and Omalizumab to NHS Scotland
Contract notice · Web page
Ustekinumab and Omalizumab
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.